Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 4/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4263651 | 0.97 | LMNA (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL1582227 | 0.97 | DNM1 (0.42) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL4261190 | 0.95 | DNM1 (0.46) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL2347365 | 0.95 | DNM1 (0.46) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL4274138 | 0.93 | LMNA (0.39) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL1582541 | 0.92 | DNM1 (0.39) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL7799148 | 0.90 | OPRM1 (0.39) | OPRM1LMNADNM1TSHRTHRB | |
| SCHEMBL3899908 | 0.86 | DNM1 (0.36) | LMNADNM1TSHRFDPS | |
| SCHEMBL21232740 | 0.84 | LMNA (0.52) | LMNATSHRSMPD1SPHK1 | |
| SCHEMBL4263383 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180030069-A1 | THIENOTHIOPHENE - BORON (DONOR-ACCEPTOR) BASED MATERIALS FOR ORGANIC LIGHT EMITTING DIODES | TUBITAK (TR) | 2018-02-01 | — | — | US | disclosed |
| EP-3259275-A1 | THIENOTHIOPHENE AND DITHIENOTHIOPHENE - BORON (DONOR-ACCEPTOR) BASED MATERIALS FOR ORGANIC LIGHT EMITTING DIODES | Tubitak (TR) | 2017-12-27 | — | — | EP | disclosed |
| WO-2016132180-A1 | THIENOTHIOPHENE AND DITHIENOTHIOPHENE - BORON (DONOR-ACCEPTOR) BASED MATERIALS FOR ORGANIC LIGHT EMITTING DIODES | TUBITAK (TR) | 2016-08-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030069-A1 | THIENOTHIOPHENE - BORON (DONOR-ACCEPTOR) BASED MATERIALS FOR ORGANIC LIGHT EMITTING DIODES | OCIAD2, OCIAD1, MBTD1 | OPRM1 506/4885LMNA 4700/4885DNM1 3333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.